P Travade
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research 11
-
- Lymphoma Diagnosis and Treatment 7
- Immunology top 10%
- Immunodeficiency and Autoimmune Disorders 6
- Hematology top 10%
- Acute Myeloid Leukemia Research 2
- Chronic Myeloid Leukemia Treatments 2
-
- Neutropenia and Cancer Infections 3
- Vascular Tumors and Angiosarcomas 1
-
- Hematological disorders and diagnostics 2
P Travade
19 papers receiving 417 citations
Peers
Comparison fields: 5 of 42
- Genetics 361
- Pathology and Forensic Medicine 246
- Immunology 230
- Hematology 78
- Physiology 10
Countries citing papers authored by P Travade
This map shows the geographic impact of P Travade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Travade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Travade more than expected).
Fields of papers citing papers by P Travade
This network shows the impact of papers produced by P Travade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Travade. The network helps show where P Travade may publish in the future.
Co-authorship network
The 25 scholars most cited alongside P Travade, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 2 | |
| 2 | 2004 | 37 | |
| 3 | [A case of primary non-Hodgkin lymphoma of the lacrimal sac]. | 2002 | 5 |
| 4 | 2000 | 7 | |
| 5 | 2000 | 6 | |
| 6 | 1997 | 19 | |
| 7 | 1997 | 11 | |
| 8 | 1997 | 2 | |
| 9 | 1992 | 44 | |
| 10 | 1991 | 260 | |
| 11 | The experience of the French Cooperative Group in the treatment of CLL. | 1990 | 5 |
| 12 | [Treatment of infection in granulopenic patients. Lessons from international studies]. | 1988 | 1 |
| 13 | New trends in CLL treatment. | 1987 | 4 |
| 14 | [Severe infections associated with chronic lymphoid leukemia. 159 infectious episodes in 60 patients]. | 1986 | 18 |
| 15 | 1986 | 5 | |
| 16 | Duplication of part of the short arm of A1 in a case of erythroleukemia (M6). | 1986 | 1 |
| 17 | 1985 | 1 | |
| 18 | 1985 | 1 | |
| 19 | 1984 | 4 | |
| 20 | 1983 | 6 |
About P Travade
P Travade is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine, having authored 20 papers that have together received 439 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (11 papers), Lymphoma Diagnosis and Treatment (7 papers), Immunodeficiency and Autoimmune Disorders (6 papers), Neutropenia and Cancer Infections (3 papers), Acute Myeloid Leukemia Research (2 papers), Chronic Myeloid Leukemia Treatments (2 papers), Hematological disorders and diagnostics (2 papers) and Vascular Tumors and Angiosarcomas (1 paper). The work is most often cited by research in Genetics (361 citations), Pathology and Forensic Medicine (246 citations) and Immunology (230 citations). P Travade has collaborated with scholars based in France, Belgium and Italy. Frequent co-authors include Guillaume Dighiero, Sylvie Chevret, Claude Chastang, JL Binet, Pierre Fenaux, Christian Magnac, J. L. Binet, Françoise Vuillier, C. Vandenvelde and B Desablens. Their work appears in journals such as British Journal of Haematology, Acta Paediatrica, The Hematology Journal, Annals of Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.